title: Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand.
abstract: The aim of this study was to compare the performance of differential polymerase chain reaction (PCR) typing and peptide enzyme-linked immunosorbent assay (V3-EIA) for human immunodeficiency virus type 1 (HIV-1) subtyping in Thailand using heteroduplex mobility assay (HMA) as the reference standard. Paired peripheral blood mononuclear cells (PBMC) and sera were collected from 38 HIV-1 seropositive persons in Thailand. HMA was done by standard methods; differential PCR employs primer pairs that differentially amplify either subtype E or B. V3-EIA used peptides specific for subtypes E or B. Thirty-two cases (84%) were found by HMA to be infected with subtype E: and six with (16%) subtype B. The results obtained with differential PCR were 100% concordant with those of HMA; V3 EIA correctly predicted the subtype in 95% (36 of 38). Six samples that molecularly subtyped as E were repeatedly dual reactive by screening V3-EIA, but these resolved to subtype E using an antigen-limiting EIA. Two samples were serologically nontypeable because of overall low levels of V3 antibody. Using HMA as the standard, differential PCR was shown to subtype HIV-1 reliably from patient PBMC samples. V3-EIA correctly predicted HIV-1 subtype in most (95%) of our cases. Because of the less rigorous sampling requirements, specimen processing, and logistical and technical requirements of serotyping compared with molecular techniques, it appears to be practical for screening purposes in a field environment. Samples that cannot be definitively subtyped serologically should undergo differential PCR and antigen-limiting V3 EIA. These approaches to HIV-1 subtyping should be used in complementary fashion in Thailand, where subtypes B and E are currently known to cocirculate.
authors.affiliation: Royal Thai Army, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
authors.forename: J
authors.initials: J
authors.lastname: Gaywee
authors.forename: A W
authors.initials: AW
authors.lastname: Artenstein
authors.forename: T C
authors.initials: TC
authors.lastname: VanCott
authors.forename: R
authors.initials: R
authors.lastname: Trichavaroj
authors.forename: A
authors.initials: A
authors.lastname: Sukchamnong
authors.forename: P
authors.initials: P
authors.lastname: Amlee
authors.forename: M
authors.initials: M
authors.lastname: de Souza
authors.forename: F E
authors.initials: FE
authors.lastname: McCutchan
authors.forename: J K
authors.initials: JK
authors.lastname: Carr
authors.forename: L E
authors.initials: LE
authors.lastname: Markowitz
authors.forename: R
authors.initials: R
authors.lastname: Michael
authors.forename: S
authors.initials: S
authors.lastname: Nittayaphan
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D004279:DNA, Viral / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005260:Female; D015483:HIV Antibodies / Q000032:analysis; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015658:HIV Infections / Q000453:epidemiology / Q000821:virology*; D015497:HIV-1 / Q000145:classification* / Q000235:genetics / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009692:Nucleic Acid Heteroduplexes; D010455:Peptides / Q000737:chemistry / Q000276:immunology; D016133:Polymerase Chain Reaction / Q000379:methods*; D012703:Serotyping; D013785:Thailand / Q000453:epidemiology
chemical_list: D004279:DNA, Viral; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D009692:Nucleic Acid Heteroduplexes; D010455:Peptides